GPT Healthcare Ltd

GPT Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

GPT Healthcare Ltd

₹ 167 3.29%
21 Nov - close price
ilshospitals.com BSE: 544131 NSE: GPTHEALTH
About

Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]

Key Points

Business Overview:[1]
GPTHL has established NABH & NABL accredited Right Sized and Full Service 4 Multi-speciality Hospitals by the name of ILS Salt Lake, ILS Agartala, ILS Dum Dum,
ILS Howrah. These hospitals have
a total capacity of 561 Beds, 90 Full
-time consultants, and 560 Visiting
consultants

Website BSE NSE
  • Market Cap ₹ 1,370 Cr.
  • Current Price ₹ 167
  • High / Low ₹ 220 / 129
  • Stock P/E 27.9
  • Book Value ₹ 28.2
  • Dividend Yield 1.50 %
  • ROCE 30.3 %
  • ROE 24.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 25.6%
  • Company has been maintaining a healthy dividend payout of 54.2%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE Healthcare BSE IPO BSE Allcap BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
82 93 96 96 108 97 99 98 106
67 73 72 77 83 76 76 80 82
Operating Profit 15 20 24 19 25 21 23 18 23
OPM % 18% 22% 25% 20% 23% 22% 23% 18% 22%
2 1 2 1 1 1 2 2 3
Interest 2 2 3 2 2 2 2 1 1
Depreciation 3 4 4 4 4 4 5 5 5
Profit before tax 11 15 19 14 19 16 18 15 21
Tax % 30% 44% 46% 30% 31% 28% 30% 32% 28%
8 8 10 10 14 11 13 10 15
EPS in Rs 0.96 1.05 1.30 1.25 1.69 1.44 1.56 1.21 1.81
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
212 243 337 361 400 400
176 194 263 287 312 314
Operating Profit 36 49 74 74 88 86
OPM % 17% 20% 22% 21% 22% 21%
4 6 5 6 5 8
Interest 14 14 11 9 7 5
Depreciation 11 12 14 15 18 19
Profit before tax 15 29 54 56 68 70
Tax % 26% 27% 23% 30% 30%
11 21 42 39 48 49
EPS in Rs 6.11 11.76 5.21 4.88 5.82 6.02
Dividend Payout % 0% 0% 0% 102% 60%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 18%
TTM: 2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 32%
TTM: 16%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 26%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 18 18 80 80 82 82
Reserves 109 116 78 85 136 149
157 166 102 82 31 28
25 18 63 79 96 88
Total Liabilities 308 317 323 327 346 347
226 220 220 228 224 222
CWIP 2 0 1 3 6 13
Investments 1 1 10 13 30 39
80 97 92 83 85 73
Total Assets 308 317 323 327 346 347

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
41 43 66 66 69
-54 -16 -5 5 -25
12 -22 -57 -73 -48
Net Cash Flow -1 4 3 -2 -5

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 30 26 15 21 22
Inventory Days 60 41 30 43 36
Days Payable 314 165 121 161 165
Cash Conversion Cycle -224 -98 -76 -97 -106
Working Capital Days 9 36 29 8 -5
ROCE % 14% 23% 25% 30%

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2024Jun 2024Sep 2024
65.57% 65.57% 65.57%
6.68% 5.38% 4.70%
11.61% 11.88% 10.80%
16.14% 17.16% 18.92%
No. of Shareholders 76,66471,29374,737

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls